This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Edgewise Therapeutics, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Marc Justin Evanchik: Innovator in Cardiac Disease Treatment
Introduction
Marc Justin Evanchik is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiac diseases. His innovative work has led to the development of unique compounds that hold promise for improving patient outcomes.
Latest Patents
Marc holds a patent for "Quinolinone amide compounds and uses thereof." This patent relates to substituted quinolinone amide compounds or salts of specific formulas. These compounds may be utilized in pharmaceutical compositions aimed at treating or preventing cardiac disease in individuals in need.
Career Highlights
Marc is currently associated with Edgewise Therapeutics, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective treatments that can significantly impact the lives of those suffering from cardiac conditions.
Collaborations
One of Marc's notable coworkers is Natalie Anne Hawryluk. Their collaboration exemplifies the teamwork necessary in the field of pharmaceutical innovation.
Conclusion
Marc Justin Evanchik's contributions to the development of quinolinone amide compounds highlight his commitment to addressing cardiac diseases through innovative solutions. His work at Edgewise Therapeutics, Inc. continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile